Profile | Garo Armen

One night in 1978 in the middle of the energy crisis, Garo Armen was driving home from his job as a research associate in photosynthesis at Brookhaven National Laboratories in Long Island, NY, when he stopped at a gas station.

Written byVicki Brower
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

One night in 1978 in the middle of the energy crisis, Garo Armen was driving home from his job as a research associate in photosynthesis at Brookhaven National Laboratories in Long Island, NY, when he stopped at a gas station. "I noticed that gas pumps only had two digits [for the per gallon price]," recalls Armen, now CEO of New York City-based Antigenics. "Realizing that continued rising prices would force the pumps to be replaced in the near future, I borrowed $5,000 to invest in gas pumps." Soon enough, virtually every gas pump in America was replaced – and Armen had made $20,000. His interest in business was piqued, and had already paid off.

Armen earned a PhD in chemistry in 1979, but with an interest in financial markets kindled, he moved to Wall Street in 1981 where he worked for financial services firm E.F. Hutton as a chemical and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies